BARLETTA, FRANCESCO MARIA
 Distribuzione geografica
Continente #
EU - Europa 1.577
NA - Nord America 1.161
AS - Asia 1.121
SA - Sud America 154
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 25
OC - Oceania 1
Totale 4.125
Nazione #
US - Stati Uniti d'America 1.097
RU - Federazione Russa 959
SG - Singapore 432
CN - Cina 327
IT - Italia 215
BR - Brasile 112
HK - Hong Kong 105
VN - Vietnam 97
SE - Svezia 90
DE - Germania 77
BD - Bangladesh 51
GB - Regno Unito 50
FR - Francia 49
FI - Finlandia 37
IN - India 37
CA - Canada 32
NL - Olanda 24
MX - Messico 21
PL - Polonia 21
AR - Argentina 19
ES - Italia 13
ZA - Sudafrica 12
AT - Austria 11
BE - Belgio 9
JP - Giappone 9
EC - Ecuador 7
TR - Turchia 7
IQ - Iraq 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
PH - Filippine 5
SA - Arabia Saudita 5
UA - Ucraina 5
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
IE - Irlanda 3
PY - Paraguay 3
UZ - Uzbekistan 3
DZ - Algeria 2
PE - Perù 2
PK - Pakistan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
Totale 4.040
Città #
Moscow 173
Singapore 171
Ashburn 158
Dallas 147
Hong Kong 102
San Jose 98
New York 76
Milan 70
Beijing 54
Shanghai 51
Council Bluffs 47
Los Angeles 45
Santa Clara 34
Hefei 30
Ho Chi Minh City 30
Munich 30
Lauterbourg 25
Hanoi 22
Rome 19
Turku 19
Orem 18
Warsaw 17
Chennai 16
Frankfurt am Main 16
Boardman 15
Lawrence 15
Princeton 15
Buffalo 14
São Paulo 14
Chicago 13
Phoenix 13
Helsinki 11
Memphis 11
Montreal 11
Nuremberg 11
Amsterdam 10
Denver 10
Atlanta 9
Brooklyn 9
Houston 9
London 9
Mexico City 9
Stockholm 9
Tokyo 9
Guangzhou 8
Johannesburg 8
Manchester 8
Da Nang 7
Seattle 7
Turin 6
Brussels 5
Chongqing 5
Columbus 5
Dalian 5
Lappeenranta 5
Mumbai 5
Naples 5
Poplar 5
Querétaro 5
San Francisco 5
The Dalles 5
Toronto 5
Barnet 4
Cerano 4
Kuala Lumpur 4
Miami 4
Milwaukee 4
Monza 4
Oudehaske 4
Porto Alegre 4
Pune 4
Valencia 4
Vancouver 4
Ankara 3
Belo Horizonte 3
Biên Hòa 3
Boston 3
Cesano Boscone 3
City of London 3
Dublin 3
Edinburgh 3
Figino 3
Guayaquil 3
Jackson 3
Manassas 3
Omaha 3
Paderborn 3
Quito 3
Tashkent 3
Thrissur 3
Tianjin 3
Vienna 3
Vimodrone 3
Zhuhai 3
Abu Dhabi 2
Acalanes Ridge 2
Aryanah 2
Asunción 2
Baie-D'Urfé 2
Bauru 2
Totale 1.917
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 228
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 178
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 163
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 152
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 146
Impact of Pacemaker Implantation After Transcatheter Aortic Valve Replacement on Long-Term Survival in Patients With Bicuspid Aortic Valve 142
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 130
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 129
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 128
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 128
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 127
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 124
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 124
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 119
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 119
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 113
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 112
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 110
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 106
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 106
DNA methylation alterations in prostate cancer: from diagnosis to treatment 104
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 104
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 102
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 101
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 96
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 92
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 90
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 88
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 84
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 77
Extra- Mitral Valve Cardiac Involvement in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edgeto- Edge Repair 77
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 76
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 73
Prognostic Significance of Flail Mitral Leaflet in Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation 71
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 64
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score 18
Totale 4.125
Categoria #
all - tutte 17.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202225 0 7 1 11 0 0 1 2 0 0 0 3
2022/2023141 37 29 12 8 3 15 5 18 1 0 6 7
2023/2024217 4 14 26 19 20 51 1 27 5 16 13 21
2024/2025694 40 15 13 22 39 57 104 79 46 26 123 130
2025/20262.827 155 155 140 333 232 79 203 272 839 188 129 102
2026/2027213 132 81 0 0 0 0 0 0 0 0 0 0
Totale 4.125